LATEST ONCOPRESCRIBE UPDATES
Neoadjuvant KEYTRUDA® plus Chemotherapy Significantly Improves EFS in Early Stage High Risk Triple Negative Breast Cancer
Metformin May Reduce the Risk of Cancers, Especially GI Malignancies
FDA Approves TEVIMBRA® for Advanced Esophageal Squamous Cell Carcinoma
FDA Approves BREYANZI®, First CAR-T Cell Therapy for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma